Class information for: |
Basic class information |
Hierarchy of classes |
The table includes all classes above and classes immediately below the current class. |
Terms with highest relevance score |
rank | Category | termType | chi_square | shrOfCwithTerm | shrOfTermInClass | termInClass |
---|---|---|---|---|---|---|
1 | PSORIASIS | authKW | 4247578 | 24% | 56% | 3581 |
2 | PSORIATIC ARTHRITIS | authKW | 1506467 | 8% | 62% | 1150 |
3 | DERMATOLOGY | WoSSC | 914991 | 59% | 5% | 8788 |
4 | DERMATOL | address | 445398 | 31% | 5% | 4638 |
5 | VESTNIK DERMATOLOGII I VENEROLOGII | journal | 335872 | 4% | 24% | 653 |
6 | BRITISH JOURNAL OF DERMATOLOGY | journal | 228834 | 7% | 10% | 1102 |
7 | CALCIPOTRIOL | authKW | 210624 | 1% | 70% | 142 |
8 | USTEKINUMAB | authKW | 179534 | 1% | 64% | 134 |
9 | PSORIASIS VULGARIS | authKW | 168894 | 1% | 52% | 155 |
10 | JOURNAL OF DERMATOLOGICAL TREATMENT | journal | 146594 | 2% | 22% | 314 |
Web of Science journal categories |
chi_square_rank | Category | chi_square | shrOfCwithTerm | shrOfTermInClass | termInClass |
---|---|---|---|---|---|
1 | Dermatology | 914991 | 59% | 5% | 8788 |
2 | Rheumatology | 38466 | 9% | 1% | 1412 |
3 | CYTOLOGY & HISTOLOGY | 1132 | 0% | 1% | 67 |
4 | Pharmacology & Pharmacy | 918 | 7% | 0% | 1085 |
5 | Medicine, General & Internal | 747 | 5% | 0% | 750 |
6 | Immunology | 723 | 5% | 0% | 781 |
7 | Allergy | 661 | 1% | 0% | 177 |
8 | Medicine, Research & Experimental | 374 | 3% | 0% | 469 |
9 | Pathology | 150 | 2% | 0% | 239 |
10 | Integrative & Complementary Medicine | 78 | 0% | 0% | 64 |
Address terms |
chi_square_rank | term | chi_square | shrOfCwithTerm | shrOfTermInClass | termInClass |
---|---|---|---|---|---|
1 | DERMATOL | 445398 | 31% | 5% | 4638 |
2 | PSORIAT ARTHRIT PROGRAM | 96656 | 0% | 78% | 59 |
3 | PROGNOSIS STUDIES RHEUMAT DIS | 93487 | 1% | 39% | 114 |
4 | PSORIASIS | 79707 | 0% | 66% | 57 |
5 | INVEST DERMATOL | 67791 | 1% | 40% | 80 |
6 | PSORIAT ARTHRIT CLIN | 57563 | 0% | 91% | 30 |
7 | SECT DERMATOL VENEREOL | 40694 | 0% | 30% | 64 |
8 | MURDOUGH FAMILY PSORIASIS | 40346 | 0% | 68% | 28 |
9 | HLTH SERV DERMATOL NURSING IVDP | 37539 | 0% | 57% | 31 |
10 | PSORIASIS SKIN TREATMENT | 30337 | 0% | 55% | 26 |
Journals |
chi_square_rank | term | chi_square | shrOfCwithTerm | shrOfTermInClass | termInClass |
---|---|---|---|---|---|
1 | VESTNIK DERMATOLOGII I VENEROLOGII | 335872 | 4% | 24% | 653 |
2 | BRITISH JOURNAL OF DERMATOLOGY | 228834 | 7% | 10% | 1102 |
3 | JOURNAL OF DERMATOLOGICAL TREATMENT | 146594 | 2% | 22% | 314 |
4 | JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY | 130058 | 3% | 13% | 481 |
5 | ACTA DERMATO-VENEREOLOGICA | 119571 | 3% | 11% | 507 |
6 | JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY | 82524 | 5% | 6% | 699 |
7 | ARCHIVES OF DERMATOLOGICAL RESEARCH | 81312 | 3% | 10% | 376 |
8 | JOURNAL OF INVESTIGATIVE DERMATOLOGY | 71916 | 4% | 6% | 606 |
9 | DERMATOLOGY | 44834 | 2% | 7% | 295 |
10 | JOURNAL OF DRUGS IN DERMATOLOGY | 34434 | 1% | 10% | 170 |
Author Key Words |
chi_square_rank | term | chi_square | shrOfCwithTerm | shrOfTermInClass | termInClass | LCSH search | Wikipedia search |
---|---|---|---|---|---|---|---|
1 | PSORIASIS | 4247578 | 24% | 56% | 3581 | Search PSORIASIS | Search PSORIASIS |
2 | PSORIATIC ARTHRITIS | 1506467 | 8% | 62% | 1150 | Search PSORIATIC+ARTHRITIS | Search PSORIATIC+ARTHRITIS |
3 | CALCIPOTRIOL | 210624 | 1% | 70% | 142 | Search CALCIPOTRIOL | Search CALCIPOTRIOL |
4 | USTEKINUMAB | 179534 | 1% | 64% | 134 | Search USTEKINUMAB | Search USTEKINUMAB |
5 | PSORIASIS VULGARIS | 168894 | 1% | 52% | 155 | Search PSORIASIS+VULGARIS | Search PSORIASIS+VULGARIS |
6 | PSORIASIS AREA AND SEVERITY INDEX | 121659 | 0% | 82% | 70 | Search PSORIASIS+AREA+AND+SEVERITY+INDEX | Search PSORIASIS+AREA+AND+SEVERITY+INDEX |
7 | PLAQUE PSORIASIS | 118859 | 0% | 80% | 70 | Search PLAQUE+PSORIASIS | Search PLAQUE+PSORIASIS |
8 | DITHRANOL | 105209 | 1% | 64% | 78 | Search DITHRANOL | Search DITHRANOL |
9 | PASI | 104140 | 0% | 77% | 64 | Search PASI | Search PASI |
10 | EFALIZUMAB | 100384 | 0% | 65% | 73 | Search EFALIZUMAB | Search EFALIZUMAB |
Core articles |
The table includes core articles in the class. The following variables is taken into account for the relevance score of an article in a cluster c: (1) Number of references referring to publications in the class. (2) Share of total number of active references referring to publications in the class. (3) Age of the article. New articles get higher score than old articles. (4) Citation rate, normalized to year. |
Classes with closest relation at Level 2 |